Department of Obstetrics and Gynecology, Kuopio University Hospital and University of Eastern Finland, Puijonlaaksontie 2, 70210, Kuopio, Finland.
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, P.O. Box 1627, 70211, Kuopio, Finland.
Arch Gynecol Obstet. 2023 Sep;308(3):883-891. doi: 10.1007/s00404-023-06950-9. Epub 2023 Feb 16.
To study whether different hormonal phases affect appetite regulation, food intake, and concentrations of leptin, glucagon-like peptide-1 (GLP-1), and high-sensitivity C-reactive protein (hs-CRP) during a long agonist in vitro fertilization (IVF) protocol.
Fifty-four infertile women were encountered thrice, the first of which was at the beginning of their period (low estradiol). The other two visits were during a gonadotrophin-releasing hormone (GnRH) analog downregulation (low estradiol) and at the end of a follicle-stimulating hormone (FSH) stimulation (high estradiol). The first visit was the reference; the women served as their controls. The concentrations of leptin, GLP-1, and hs-CRP were assessed from plasma. Dietary intake was assessed using food records (FRs). In addition, weight, height, body mass index (BMI), and plasma levels of estradiol, glucose, HbA1c, insulin, and lipids were monitored. Twenty-six of the subjects also had a postprandial test.
During the stimulation protocol, leptin concentrations elevated (P < 0.001), and energy intake decreased (P = 0.03), while estradiol levels increased (P < 0.001). GLP-1 levels unchanged (P = 0.75) and hs-CRP (P = 0.03) concentrations diminished, while estradiol levels increased.
No increased food intake or weight gain occurred during the stimulation protocol; thus, leptin may protect from overeating during high estradiol levels, and leptin resistance may not occur during a short follow-up. Also, a favorable anti-inflammatory effect was detected. During this study, we observed no harmful metabolic effects, which might affect negatively maternal health.
研究不同的激素阶段是否会影响食欲调节、食物摄入以及在长激动剂体外受精(IVF)方案中瘦素、胰高血糖素样肽-1(GLP-1)和高敏 C 反应蛋白(hs-CRP)的浓度。
54 名不孕妇女被遇到了三次,第一次是在她们的月经期间(低雌二醇)。另外两次访问是在促性腺激素释放激素(GnRH)类似物下调(低雌二醇)和卵泡刺激素(FSH)刺激结束时(高雌二醇)。第一次访问是参考;妇女作为她们的对照组。从血浆中评估瘦素、GLP-1 和 hs-CRP 的浓度。通过食物记录(FR)评估饮食摄入量。此外,监测体重、身高、体重指数(BMI)以及雌二醇、血糖、HbA1c、胰岛素和脂质的血浆水平。26 名受试者还进行了餐后测试。
在刺激方案期间,瘦素浓度升高(P<0.001),能量摄入减少(P=0.03),而雌二醇水平升高(P<0.001)。GLP-1 水平不变(P=0.75),hs-CRP(P=0.03)浓度降低,而雌二醇水平升高。
在刺激方案期间没有增加食物摄入或体重增加;因此,瘦素可能会防止在高雌二醇水平时过度进食,并且在短期随访期间可能不会发生瘦素抵抗。此外,还检测到有利的抗炎作用。在这项研究中,我们没有观察到任何有害的代谢影响,这可能会对母亲的健康产生负面影响。